Show
Sort by
-
Characterising normal patterns of alanine aminotransferase elevations in ursodeoxycholic acid-treated patients with primary biliary cholangitis
-
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis
-
- Journal Article
- A1
- open access
Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
-
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
-
- Journal Article
- A1
- open access
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma